BALL KRISTINE M 4
4 · Oruka Therapeutics, Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
BALL KRISTINE M
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 totalExercise: $11.77Exp: 2035-06-01→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from June 2, 2025.